We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Warburg Pincus Capital Corporation IA | NYSE:WPCA | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 10.21 | 0 | 00:00:00 |
☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Cayman Islands |
001-40171 |
98-1572641 | ||
(State or other jurisdiction of incorporation or organization) |
(Commission File Number) |
(IRS Employer Identification No.) |
450 Lexington Avenue New York, New York |
10017 | |
(Address Of Principal Executive Offices) |
(Zip Code) |
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
Units, each consisting of one Class A ordinary share, $0.0001 par value, and one-fifth of one redeemable warrant |
WPCA.U |
NYSE | ||
Class A ordinary shares included as part of the units |
WPCA |
NYSE | ||
Redeemable warrants included as part of the units |
WPCA WS |
NYSE |
Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
Non-accelerated filer | ☒ | Smaller reporting company | ☒ | |||
Emerging growth company | ☒ |
WARBURG PINCUS CAPITAL CORPORATION I-A
Form 10-Q
For the Quarter Ended September 30, 2022
Table of Contents
Item 1. |
Condensed Financial Statements |
September 30, 2022 |
December 31, 2021 |
|||||||
(Unaudited) |
||||||||
Assets: |
||||||||
Current assets: |
||||||||
Cash |
$ | 697,963 | $ | 1,237,399 | ||||
Prepaid expenses |
208,523 | 518,804 | ||||||
Total current assets |
906,486 | 1,756,203 | ||||||
Investments held in Trust Account |
285,112,371 | 283,436,447 | ||||||
Total Assets |
$ |
286,018,857 |
$ |
285,192,650 |
||||
Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit: |
||||||||
Current liabilities: |
||||||||
Accounts payable |
$ | 439,464 | $ | 193,276 | ||||
Accrued expenses |
1,255,775 | 1,036,165 | ||||||
Total current liabilities |
1,695,239 | 1,229,441 | ||||||
Derivative warrant liabilities |
1,024,550 | 11,332,920 | ||||||
Deferred underwriting commissions |
9,919,751 | 9,919,751 | ||||||
Total liabilities |
12,639,540 | 22,482,112 | ||||||
Commitments and Contingencies |
||||||||
Class A ordinary shares subject to possible redemption, $0.0001 par value; 28,342,178 shares at approximately $10.06 and $10.00 as of September 30, 2022 and December 31, 2021, respectively |
285,012,371 | 283,421,780 | ||||||
Shareholders’ Deficit: |
||||||||
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued or outstanding as of September 30, 2022 and December 31, 2021 |
— | — | ||||||
Class A ordinary shares, $0.0001 par value; 500,000,000 shares authorized; no non-redeemable shares issued or outstanding as of September 30, 2022 and December 31, 2021 |
— | — | ||||||
Class B ordinary shares, $0.0001 par value; 50,000,000 shares authorized; 7,085,544 shares issued and outstanding as of September 30, 2022 and December 31, 2021 |
709 | 709 | ||||||
Additional paid-in capital |
— | — | ||||||
Accumulated deficit |
(11,633,763 | ) | (20,711,951 | ) | ||||
Total shareholders’ deficit |
(11,633,054 | ) | (20,711,242 | ) | ||||
Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit |
$ |
286,018,857 |
$ |
285,192,650 |
||||
For the Three Months Ended September 30, |
For the Nine Months Ended September 30, |
|||||||||||||||
2022 |
2021 |
2022 |
2021 |
|||||||||||||
General and administrative expenses |
$ | 253,367 | $ | 345,816 | $ | 1,225,515 | $ | 895,456 | ||||||||
General and administrative expenses - related party |
30,000 | 30,000 | 90,000 | 70,000 | ||||||||||||
Loss from operations |
(283,367 | ) | (375,816 | ) | (1,315,515 | ) | (965,456 | ) | ||||||||
Other income (expenses): |
||||||||||||||||
Change in fair value of derivative warrant liabilities |
2,753,090 | 2,861,850 | 10,308,370 | 1,402,100 | ||||||||||||
Offering costs associated with derivative warrant liabilities |
— | — | — | (396,570 | ) | |||||||||||
Income from investments held in Trust Account |
1,267,915 | 4,317 | 1,675,924 | 9,347 | ||||||||||||
Net income |
$ | 3,737,638 | $ | 2,490,351 | $ | 10,668,779 | $ | 49,421 | ||||||||
Weighted average shares outstanding of Class A ordinary shares |
28,342,178 | 28,342,178 | 28,342,178 | 20,872,224 | ||||||||||||
Basic and diluted net income per share, Class A ordinary shares |
$ | 0.11 | $ | 0.07 | $ | 0.30 | $ | 0.00 | ||||||||
Weighted average shares outstanding of Class B ordinary shares |
7,085,544 | 7,085,544 | 7,085,544 | 6,758,060 | ||||||||||||
Basic and diluted net income per share, Class B ordinary shares |
$ | 0.11 | $ | 0.07 | $ | 0.30 | $ | 0.00 | ||||||||
Ordinary Shares |
Additional Paid-in Capital |
Accumulated Deficit |
Total Shareholders’ Deficit |
|||||||||||||||||||||||||
Class A |
Class B |
|||||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||
Balance - December 31, 2021 |
— |
$ |
— |
7,085,544 |
$ |
709 |
$ |
— |
$ |
(20,711,951 |
) |
$ |
(20,711,242 |
) | ||||||||||||||
Net income |
— | — | — | — | — | 5,346,699 | 5,346,699 | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance - March 31, 2022 (Unaudited) |
— |
— |
7,085,544 |
709 |
— |
(15,365,252 |
) |
(15,364,543 |
) | |||||||||||||||||||
Increase in redemption value of Class A ordinary shares subject to possible redemption |
— | — | — | — | — | (322,676 | ) | (322,676 | ) | |||||||||||||||||||
Net income |
— | — | — | — | — | 1,584,442 | 1,584,442 | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance - June 30, 2022 (Unaudited) |
— |
— |
7,085,544 |
709 |
— |
(14,103,486 |
) |
(14,102,777 |
) | |||||||||||||||||||
Increase in redemption value of Class A ordinary shares subject to possible redemption |
— | — | — | — | — | (1,267,915 | ) | (1,267,915 | ) | |||||||||||||||||||
Net income |
— | — | — | — | — | 3,737,638 | 3,737,638 | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance - September 30, 2022 (Unaudited) |
— |
$ |
— |
7,085,544 |
$ |
709 |
$ |
— |
$ |
(11,633,763 |
) |
$ |
(11,633,054 |
) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ordinary Shares |
Additional Paid-in Capital |
Accumulated Deficit |
Total Shareholders’ Equity (Deficit) |
|||||||||||||||||||||||||
Class A |
Class B |
|||||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||
Balance - December 31, 2020 |
— |
$ |
— |
7,187,500 |
$ |
719 |
$ |
24,281 |
$ |
(13,242 |
) |
$ |
11,758 |
|||||||||||||||
Excess cash received over the fair value of the private placement warrants |
— | — | — | — | 1,546,670 | — | 1,546,670 | |||||||||||||||||||||
Accretion of Class A ordinary shares subject to possible redemption amount |
— | — | — | — | (1,570,951 | ) | (18,402,183 | ) | (19,973,134 | ) | ||||||||||||||||||
Net income |
— | — | — | — | — | 1,352,066 | 1,352,066 | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance - March 31, 2021 (Unaudited) |
— |
— |
7,187,500 |
719 |
— |
(17,063,359 |
) |
(17,062,640 |
) | |||||||||||||||||||
Excess cash received over the fair value of the private warrants, over-allotment |
— | — | — | — | 209,446 | — | 209,446 | |||||||||||||||||||||
Forfeiture of Class B ordinary shares |
— | — | (101,956 | ) | (10 | ) | 10 | — | — | |||||||||||||||||||
Accretion of Class A ordinary shares subject to possible redemption amount, over-allotment |
— | — | — | — | (209,456 | ) | (2,279,362 | ) | (2,488,818 | ) | ||||||||||||||||||
Net loss |
— | — | — | — | — | (3,792,996 | ) | (3,792,996 | ) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance - June 30, 2021 (Unaudited) |
— |
— |
7,085,544 |
709 |
— |
(23,135,717 |
) |
(23,135,008 |
) | |||||||||||||||||||
Net income |
— | — | — | — | — | 2,490,351 | 2,490,351 | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance - September 30, 2021 (Unaudited) |
— |
$ |
— |
7,085,544 |
$ |
709 |
$ |
— |
$ |
(20,645,366 |
) |
$ |
(20,644,657 |
) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Nine Months Ended September 30, |
||||||||
2022 |
2021 |
|||||||
Cash Flows from Operating Activities: |
||||||||
Net income |
$ | 10,668,779 | $ | 49,421 | ||||
Adjustments to reconcile net income to net cash used in operating activities: |
||||||||
Income from investments held in Trust Account |
(1,675,924 | ) | (9,347 | ) | ||||
Change in fair value of derivative warrant liabilities |
(10,308,370 | ) | (1,402,100 | ) | ||||
Offering costs associated with derivative warrant liabilities |
— | 396,570 | ||||||
General and administrative expenses paid by related party under promissory note |
— | 3,053 | ||||||
Changes in operating assets and liabilities: |
||||||||
Prepaid expenses |
310,281 | (622,726 | ) | |||||
Accounts payable |
246,188 | 17,091 | ||||||
Accrued expenses |
219,610 | 410,375 | ||||||
|
|
|
|
|||||
Net cash used in operating activities |
(539,436 | ) | (1,157,663 | ) | ||||
|
|
|
|
|||||
Cash Flows from Investing Activities: |
||||||||
Cash deposited in Trust Account |
— | (283,421,780 | ) | |||||
|
|
|
|
|||||
Net cash used in investing activities |
— | (283,421,780 | ) | |||||
|
|
|
|
|||||
Cash Flows from Financing Activities: |
||||||||
Repayment of note payable to related party |
— | (78,045 | ) | |||||
Proceeds received from initial public offering |
— | 283,421,780 | ||||||
Proceeds received from private placement |
— | 8,668,435 | ||||||
Offering costs paid |
— | (5,790,277 | ) | |||||
|
|
|
|
|||||
Net cash provided by financing activities |
— | 286,221,893 | ||||||
|
|
|
|
|||||
Net change in cash |
(539,436 | ) | 1,642,450 | |||||
Cash - beginning of the period |
1,237,399 | — | ||||||
|
|
|
|
|||||
Cash - end of the period |
$ |
697,963 |
$ |
1,642,450 |
||||
|
|
|
|
|||||
Supplemental disclosure of noncash activities: |
||||||||
Offering costs included in accrued expenses |
$ | — | $ | 253,400 | ||||
Offering costs paid by related party under promissory note |
$ | — | $ | 74,992 | ||||
Deferred underwriting commissions |
$ | — | $ | 9,919,751 |
• | Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; |
• | Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and |
• | Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. |
For the Three Months Ended September 30, |
||||||||||||||||
2022 |
2021 |
|||||||||||||||
Class A |
Class B |
Class A |
Class B |
|||||||||||||
Basic and diluted net income per ordinary share: |
||||||||||||||||
Numerator: |
||||||||||||||||
Allocation of net income |
$ | 2,990,111 | $ | 747,528 | $ | 1,992,281 | $ | 498,070 | ||||||||
Denominator: |
||||||||||||||||
Basic and diluted weighted average ordinary shares outstanding |
28,342,178 | 7,085,544 | 28,342,178 | 7,085,544 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Basic and diluted net income per ordinary share |
$ | 0.11 | $ | 0.11 | $ | 0.07 | $ | 0.07 | ||||||||
|
|
|
|
|
|
|
|
For the Nine Months Ended September 30, |
||||||||||||||||
2022 |
2021 |
|||||||||||||||
Class A |
Class B |
Class A |
Class B |
|||||||||||||
Basic and diluted net income per ordinary share: |
||||||||||||||||
Numerator: |
||||||||||||||||
Allocation of net income |
$ | 8,535,024 | $ | 2,133,756 | $ | 37,333 | $ | 12,088 | ||||||||
Denominator: |
||||||||||||||||
Basic and diluted weighted average ordinary shares outstanding |
28,342,178 | 7,085,544 | 20,872,224 | 6,758,060 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Basic and diluted net income per ordinary share |
$ | 0.30 | $ | 0.30 | $ | 0.00 | $ | 0.00 | ||||||||
|
|
|
|
|
|
|
|
Gross proceeds from Initial Public Offering |
$ | 283,421,780 | ||
Less: |
||||
Fair value of Public Warrants at issuance |
(6,738,490 | ) | ||
Offering costs allocated to Class A ordinary shares subject to possible redemption |
(15,723,462 | ) | ||
Plus: |
||||
Accretion on Class A ordinary shares subject to possible redemption amount |
22,461,952 | |||
Class A ordinary shares subject to possible redemption as of December 31, 2021 |
283,421,780 | |||
Increase in redemption value of Class A ordinary shares subject to possible redemption |
322,676 | |||
Class A ordinary shares subject to possible redemption as of June 30, 2022 |
283,744,456 | |||
Increase in redemption value of Class A ordinary shares subject to possible redemption |
1,267,915 | |||
Class A ordinary shares subject to possible redemption as of September 30, 2022 |
$ | 285,012,371 |
• | in whole and not in part; |
• | at a price of $0.01 per warrant; |
• | upon not less than 30 days’ prior written notice of redemption to each warrant holder; and |
• | if, and only if, the last reported sale price (the “closing price”) of Class A ordinary shares equals or exceeds $18.00 per share (as adjusted) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders. |
• | in whole and not in part; |
• | at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to an agreed table based on the redemption date and the “fair market value” of Class A ordinary shares; |
• | if, and only if, the Reference Value equals or exceeds $10.00 per share (as adjusted); and |
• | if the Reference Value is less than $18.00 per share (as adjusted), the Private Placement Warrants must also concurrently be called for redemption on the same terms as the outstanding Public Warrants, as described above. |
September 30, 2022 |
||||||||||||
Description |
Quoted Prices in Active Markets (Level 1) |
Significant Other Observable Inputs (Level 2) |
Significant Other Unobservable Inputs (Level 3) |
|||||||||
Assets: |
||||||||||||
Investments held in Trust Account-money market funds |
$ | 285,112,371 | $ | — | $ | — | ||||||
Liabilities: |
||||||||||||
Derivative warrant liabilities-Public warrants |
$ | 507,330 | $ | — | $ | — | ||||||
Derivative warrant liabilities-Private placement warrants |
$ | — | $ | 517,220 | $ | — |
December 31, 2021 |
||||||||||||
Description |
Quoted Prices in Active Markets (Level 1) |
Significant Other Observable Inputs (Level 2) |
Significant Other Unobservable Inputs (Level 3) |
|||||||||
Assets: |
||||||||||||
Investments held in Trust Account-money market funds |
$ | 283,436,447 | $ | — | $ | — | ||||||
Liabilities: |
||||||||||||
Derivative warrant liabilities-Public warrants |
$ | — | $ | — | $ | 5,611,750 | ||||||
Derivative warrant liabilities-Private placement warrants |
$ | — | $ | — | $ | 5,721,170 |
December 31, 2021 |
||||
Exercise price |
$ | 11.50 | ||
Unit price |
$ | 9.80 | ||
Volatility |
14.9 | % | ||
Term (years) |
5.0 | |||
Risk-free rate |
1.30 | % |
Derivative warrant liabilities at January 1, 2021 |
$ | — | ||
Issuance of Public and Private Warrants |
12,503,330 | |||
Change in fair value of derivative warrant liabilities |
(1,860,000 | ) | ||
Derivative warrant liabilities at March 31, 2021 |
10,643,330 | |||
Issuance of Public and Private Warrants - over-allotment |
1,147,480 | |||
Change in fair value of derivative warrant liabilities |
3,319,750 | |||
Derivative warrant liabilities at June 30, 2021 |
15,110,560 | |||
Change in fair value of derivative warrant liabilities |
(2,861,850 | ) | ||
Derivative warrant liabilities at September 30, 2021 |
$ | 12,248,710 | ||
Derivative warrant liabilities at January 1, 2022 |
$ | 11,332,920 | ||
Transfer of Public Warrants to Level 1 |
(5,611,750 | ) | ||
Transfer of Private Placement Warrants to Level 2 |
(5,721,170 | ) | ||
Derivative warrant liabilities at March 31, 2022 |
— | |||
Transfer of Public Warrants to Level 3 |
2,664,160 | |||
Transfer of Private Placement Warrants to Level 3 |
2,716,110 | |||
Change in fair value of derivative warrant liabilities |
(1,602,630 | ) | ||
Derivative warrant liabilities at June 30, 2022 |
3,777,640 | |||
Transfer of Public Warrants to Level 1 |
(1,870,580 | ) | ||
Transfer of Private Placement Warrants to Level 2 |
(1,907,060 | ) | ||
Derivative warrant liabilities at September 30, 2022 |
$ | — | ||
Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations. |
References to the “Company,” “Warburg Pincus Capital Corporation I-A,” “Warburg Pincus,” “our,” “us” or “we” refer to Warburg Pincus Capital Corporation I-A. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the unaudited interim condensed financial statements and the notes thereto contained elsewhere in this report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.
Cautionary Note Regarding Forward-Looking Statements
This Quarterly Report on Form 10-Q (this “Quarterly Report”) includes forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “continue,” or the negative of such terms or other similar expressions. Factors that might cause or contribute to such a discrepancy include, but are not limited to, those described in our other SEC filings.
Overview
We are a blank check company incorporated as a Cayman Islands exempted company on December 1, 2020. We were formed for the purpose of effecting an initial Business Combination. We are an emerging growth company and, as such, we are subject to all of the risks associated with emerging growth companies.
Our Sponsor is Warburg Pincus Capital Corporation I-A Sponsor, L.P. The registration statement for our Initial Public Offering was declared effective on March 4, 2021. On March 9, 2021, we consummated our Initial Public Offering of 25,000,000 Units, at $10.00 per Unit, generating gross proceeds of $250.0 million, and incurring offering costs of approximately $14.3 million, of which approximately $8.8 million was for deferred underwriting commissions. On April 16, 2021, the underwriters partially exercised the over-allotment option, and the closing of the issuance and sale of the 3,342,178 Over-Allotment Units occurred on April 20, 2021. The issuance by us of the over-allotment units at a price of $10.00 per such units resulted in total gross proceeds of approximately $33.4 million, and the incurrence of approximately $1.8 million in offering costs, of which approximately $1.2 million was for deferred underwriting commissions.
Simultaneously with the closing of our Initial Public Offering, we consummated the IPO Private Placement of 5,333,333 Private Placement Warrants, at a price of $1.50 per private placement warrant with the Sponsor, generating gross proceeds of $8.0 million. On April 20, 2021, simultaneously with the issuance and sale of the Over-Allotment Units, we consummated the sale of an additional 445,624 Private Placement Warrants pursuant to the Over-Allotment Private Placement, generating gross proceeds of approximately $668,000.
The Offering Proceeds (approximately $283.4 million in the aggregate) were placed in our Trust Account with Continental Stock Transfer & Trust Company acting as trustee and will be invested in United States government treasury bills with a maturity of 185 days or less or in money market funds investing solely in U.S. Treasuries and meeting certain conditions under Rule 2a-7 under the Investment Company Act, as determined by us, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below. Our management has broad discretion with respect to the specific application of the Offering Proceeds, although substantially all of such proceeds are intended to be applied generally toward consummating a Business Combination. Our initial Business Combination must be with one or more operating businesses or assets with a fair market value equal to at least 80% of the net assets held in the Trust Account (excluding the deferred underwriting commissions and taxes payable on the interest earned on the Trust Account) at the time we sign a definitive agreement in connection with the initial Business Combination. However, we will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act.
20
If we are unable to complete an initial Business Combination within 24 months from the closing of our Initial Public Offering, or March 9, 2023, we will (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem our Class A ordinary shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to us to pay our taxes, if any (less up to $100,000 of interest to pay dissolution expenses), divided by the number of the then-outstanding Class A ordinary shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidating distributions, if any); and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the board of directors, liquidate and dissolve, subject in the case of clauses (ii) and (iii), to our obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.
Liquidity and Going Concern
As of September 30, 2022, we had approximately $0.7 million in our operating bank account and a working capital deficit of approximately $0.8 million.
Our liquidity needs through September 30, 2022 have been satisfied through a payment of $25,000 from the Sponsor to cover for certain expenses in exchange for the issuance of the Founder Shares, a loan of approximately $78,000 from the Sponsor pursuant to the Note, dated December 9, 2020, where the Sponsor agreed to loan us up to $300,000 for the payment of costs related to our Initial Public Offering, and the proceeds from the consummation of the Private Placements not held in the Trust Account. We repaid the Note in full on March 9, 2021. In addition, in order to finance transaction costs in connection with an initial Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of our officers and directors may, but are not obligated to, provide us Working Capital Loans. As of September 30, 2022 and December 31, 2021, there were no amounts outstanding under any Working Capital Loans to the Company.
Based on the foregoing, management believes that the Company will have the borrowing capacity from its Sponsor or an affiliate of its Sponsor, or its officers and directors to meet the Company’s needs through the consummation of a Business Combination. However, in connection with the Company’s assessment of going concern considerations in accordance with FASB Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that the mandatory liquidation and subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after March 9, 2023. The condensed financial statements do not include any adjustment that might be necessary if the Company is unable to continue as a going concern. The Company intends to complete a Business Combination before the mandatory liquidation date. Over this time period, the Company will be using the funds outside of the Trust Account for paying existing accounts payable, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Business Combination.
Management continues to evaluate the impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on our financial position, results of our operations and/or search for a target company, the specific impact is not readily determinable as of the date of the condensed financial statements. The condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty.
In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. Further, the impact of this action and related sanctions on the world economy are not determinable as of the date of these financial statements. The specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as of the date of these unaudited condensed financial statements.
21
Results of Operations
Our entire activity from inception up to September 30, 2022 was in preparation for our formation, our Initial Public Offering and our search for a Business Combination. We will not be generating any operating revenues until the closing and completion of our initial Business Combination at the earliest.
For the three months ended September 30, 2022, we had a net income of approximately $3,738,000, which consisted of approximately $2,753,000 in non-operating gain resulting from the change in fair value of derivative warrant liabilities, and approximately $1,268,000 of income from investments held in the Trust Account, partially offset by approximately $283,000 in general and administrative expenses.
For the three months ended September 30, 2021, we had a net income of approximately $2,490,000, which consisted of approximately $4,000 of income from investments held in the Trust Account, and approximately $2,862,000 in non-operating gain resulting from the change in fair value of derivative warrant liabilities, offset by approximately $376,000 in general and administrative expenses.
For the nine months ended September 30, 2022, we had a net income of approximately $10,669,000, which consisted of approximately $10,308,000 in non-operating gain resulting from the change in fair value of derivative warrant liabilities, and approximately $1,676,000 of income from investments held in the Trust Account, partially offset by approximately $1,316,000 in general and administrative expenses.
For the nine months ended September 30, 2021, we had a net income of approximately $49,000, which consisted of approximately $9,000 of income from investments held in the Trust Account, approximately $1,402,000 in non-operating gain resulting from the change in fair value of derivative warrant liabilities, offset by approximately $397,000 in offering costs associated with derivative warrant liabilities, and approximately $965,000 in general and administrative expenses.
Contractual Obligations
Registration Rights
The holders of the Founder Shares, Private Placement Warrants and any warrants that may be issued upon conversion of Working Capital Loans (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants or warrants issued upon conversion of any outstanding Working Capital Loans) were entitled to registration rights pursuant to that certain Registration Rights Agreement, dated March 9, 2021, by and between us, the Sponsor and certain of our directors. The holders of these securities are entitled to make up to three demands, excluding short form demands, that we register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of the initial Business Combination. We will bear the expenses incurred in connection with the filing of any such registration statements.
Underwriting Agreement
We granted the underwriters a 45-day option from the date of the Initial Public Offering to purchase up to 3,750,000 additional Units at the Initial Public Offering price less the underwriting discounts and commissions. On April 16, 2021, the underwriters partially exercised the over-allotment option to purchase the Over-Allotment Units (see Note 1).
The underwriters were entitled to an underwriting discount of $0.20 per unit, or approximately $5.0 million and $0.7 million ($5.7 million in the aggregate), paid upon the closing of the Initial Public Offering and the sale of the Over-Allotment Units, respectively. In addition, $0.35 per unit, or approximately $9.9 million in the aggregate will be payable to the underwriters for deferred underwriting commissions. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that we complete a Business Combination, subject to the terms of the underwriting agreement.
22
Administrative Services Agreement
Commencing on the date that our securities were first listed on the New York Stock Exchange through the earlier of consummation of the initial Business Combination or its liquidation, we agreed to reimburse the Sponsor or an affiliate of the Sponsor for office space, secretarial and administrative services provided to us in the amount of $10,000 per month.
In addition, the Sponsor, officers and directors, or any of their respective affiliates will be reimbursed for any out-of-pocket expenses incurred in connection with activities on our behalf such as identifying potential target businesses and performing due diligence on suitable Business Combinations. Our audit committee will review on a quarterly basis all payments that were made to the Sponsor, officers or directors, or their respective affiliates. Any such payments prior to an initial Business Combination will be made from funds held outside the Trust Account.
For the three months ended September 30, 2022 and 2021, we incurred expenses of $30,000 under this agreement, respectively. For the nine months ended September 30, 2022 and 2021, we incurred expenses of $90,000 and $70,000 under this agreement, respectively. As of September 30, 2022 and December 31, 2021, we had payables of approximately $80,000 and $10,000, for services in connection with such agreement on the accompanying condensed balance sheets, respectively.
In January 2022, the Company entered into a cost sharing arrangement with a related party.
Critical Accounting Policies
Derivative Warrant Liabilities
We do not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. We evaluate all of our financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC 815. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.
The Warrants are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the carrying value of the instruments to fair value at each reporting period until they are exercised. The initial fair value and when the quoted price is not available of the Public Warrants issued in connection with the Initial Public Offering and the fair value of the Private Placement Warrants have been estimated using a binomial lattice model in a risk-neutral framework. As the transfer of Private Placement Warrants to anyone who is not a permitted transferee would result in the Private Placement Warrants having substantially the same terms as the Public Warrants, the Company determined that the fair value of each Private Placement Warrant is equivalent to that of each Public Warrant. The fair value of the Public Warrants and Private Placement Warrants as of December 31, 2021 was determined based on the binomial lattice model. The fair value of the Public Warrants and Private Placement Warrants as of September 30, 2022 was determined based on the instrument’s publicly listed trading price. The determination of the fair value of the warrant liability may be subject to change as more current information becomes available and accordingly the actual results could differ significantly. Derivative warrant liabilities are classified as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.
Class A Ordinary Shares Subject to Possible Redemption
We account for our Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Class A ordinary shares subject to mandatory redemption (if any) is classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class ordinary shares that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within our control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. Our Class A ordinary shares feature certain redemption rights that are considered to be outside of our control and subject to the occurrence of uncertain future events. Accordingly, as of Initial Public Offering, 28,342,178 Class A ordinary shares subject to possible redemption is presented at redemption value as temporary equity, outside of the shareholders’ equity section of our condensed balance sheets.
23
Effective with the closing of the Initial Public Offering, we recognized the accretion from initial book value to redemption amount, which resulted in charges against additional paid-in capital (to the extent available) and accumulated deficit.
Net Income (Loss) per Ordinary Share
We comply with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” We have two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. Net income (loss) per ordinary share is calculated by dividing the net income (loss) by the weighted average shares of ordinary shares outstanding for the respective period.
The calculation of diluted net income (loss) does not consider the effect of the Public Warrants underlying the Units sold in the Initial Public Offering (including exercise of the Over-Allotment Option) and the Private Placement Warrants to purchase an aggregate of 11,447,393 Class A ordinary shares in the calculation of diluted income (loss) per share, because their exercise is contingent upon future events and their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted net income (loss) per share is the same as basic net income (loss) per share for the three and nine months ended September 30, 2022 and 2021. Accretion associated with the redeemable Class A ordinary shares is excluded from earnings per share as the redemption value approximates fair value.
Recent Accounting Pronouncements
In June 2022, the FASB issued ASU 2022-03, ASC Subtopic 820 “Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions.” The ASU amends ASC 820 to clarify that a contractual sales restriction is not considered in measuring an equity security at fair value and to introduce new disclosure requirements for equity securities subject to contractual sale restrictions that are measured at fair value. The ASU applies to both holders and issuers of equity and equity-linked securities measured at fair value. The amendments in this ASU are effective for the Company in fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. Early adoption is permitted for both interim and annual financial statements that have not yet been issued or made available for issuance. The Company is still evaluating the impact of this pronouncement on the condensed financial statements.
The Company’s management does not believe that any recently issued, but not yet effective, accounting standards updates, if currently adopted, would have a material effect on the Company’s unaudited condensed financial statements.
Off-Balance Sheet Arrangements
As of September 30, 2022, we did not have any off-balance sheet arrangements as defined in Item 303(a)(4)(ii) of Regulation S-K.
JOBS Act
The JOBS Act contains provisions that, among other things, relax certain reporting requirements for qualifying public companies. We qualify as an “emerging growth company” and under the JOBS Act are allowed to comply with new or revised accounting pronouncements based on the effective date for private (not publicly traded) companies. We are electing to delay the adoption of new or revised accounting standards, and as a result, we may not comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for non-emerging growth companies. As a result, the condensed financial statements may not be comparable to companies that comply with new or revised accounting pronouncements as of public company effective dates.
Additionally, we are in the process of evaluating the benefits of relying on the other reduced reporting requirements provided by the JOBS Act. Subject to certain conditions set forth in the JOBS Act, if, as an “emerging growth company,” we choose to rely on such exemptions we may not be required to, among other things, (i) provide an auditor’s attestation report on our system of internal controls over financial reporting pursuant to Section 404, (ii)
24
provide all of the compensation disclosure that may be required of non-emerging growth public companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act, (iii) comply with any requirement that may be adopted by the Public Company Accounting Oversight Board regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the condensed financial statements (auditor discussion and analysis) and (iv) disclose certain executive compensation related items such as the correlation between executive compensation and performance and comparisons of the CEO’s compensation to median employee compensation. These exemptions will apply for a period of five years following the completion of our Initial Public Offering or until we are no longer an “emerging growth company,” whichever is earlier.
Item 3. | Quantitative and Qualitative Disclosures About Market Risk |
We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this item. As of September 30, 2022, we were not subject to any market or interest rate risk, other than that related to derivative warrant liabilities. The Offering Proceeds, including amounts in the Trust Account, was invested in U.S. government securities with a maturity of 185 days or less or in money market funds that meet certain conditions under Rule 2a-7 under the Investment Company Act that invest only in direct U.S. government treasury obligations. Due to the short-term nature of these investments, we believe there will be no associated material exposure to interest rate risk.
We have not engaged in any hedging activities since our inception, and we do not expect to engage in any hedging activities with respect to the market risk to which we are exposed.
Item 4. | Controls and Procedures |
Evaluation of Disclosure Controls and Procedures
Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures as of the end of the fiscal quarter ended September 30, 2022, as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on this evaluation, our principal executive officer and principal financial officer has concluded that during the period covered by this report, our disclosure controls and procedures were effective as of September 30, 2022.
Disclosure controls and procedures are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.
Changes in Internal Control over Financial Reporting
There was no change in our internal control over financial reporting that occurred during the fiscal quarter ended September 30, 2022 covered by this Quarterly Report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
PART II-OTHER INFORMATION
Item 1. | Legal Proceedings |
None.
Item 1A. | Risk Factors |
As of the date of this Quarterly Report on Form 10-Q, there have been no material changes to the risk factors disclosed in our Annual Report on Form 10-K filed by the Company with the SEC on March 7, 2022 except as set forth below.
25
We may disclose changes to such factors or disclose additional factors from time to time in our future filings with the SEC.
Changes In Laws Or Regulations, Or A Failure To Comply With Any Laws And Regulations, May Adversely Affect Our Business, Including Our Ability To Negotiate And Complete Our Initial Business Combination, And Results Of Operations.
We are subject to laws and regulations enacted by national, regional and local governments. In particular, we will be required to comply with certain SEC and other legal requirements. Compliance with, and monitoring of, applicable laws and regulations may be difficult, time consuming and costly. Those laws and regulations and their interpretation and application may also change from time to time and those changes could have a material adverse effect on our business, investments and results of operations. In addition, a failure to comply with applicable laws or regulations, as interpreted and applied, could have a material adverse effect on our business, including our ability to negotiate and complete our initial business combination, and results of operations.
On March 30, 2022, the SEC issued proposed rules relating to, among other items, enhancing disclosures in business combination transactions involving special purpose acquisition companies, or SPACs, and private operating companies and increasing the potential liability of certain participants in proposed business combination transactions. These rules, if adopted, whether in the form proposed or in revised form, may materially increase the costs and time required to negotiate and complete an initial business combination and could potentially impair our ability to complete an initial business combination.
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds From Registered Securities. |
Simultaneously with the closing of the Initial Public Offering, we consummated the Private Placement of 5,333,333 Private Placement Warrants, at a price of $1.50 per Private Placement Warrant with the Sponsor, generating gross proceeds of $8.0 million. On April 20, 2021, simultaneously with the issuance and sale of the Over-Allotment Units, the Company consummated the sale of an additional 445,624 Private Placement Warrants pursuant to the Over-Allotment Private Placement.
In connection with the Initial Public Offering, our Sponsor had agreed to loan us an aggregate of up to $300,000 pursuant to the Note. The Note was non-interest bearing and payable on the consummation of the Initial Public Offering. On March 9, 2021, we repaid the Note in full.
Of the gross proceeds received from the Initial Public Offering and the Over-Allotment Units, $283.4 million was placed in the Trust Account. The Offering Proceeds are invested in U.S. government treasury bills with a maturity of 185 days or less and in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations.
We paid a total of approximately $5.7 million in underwriting discounts and commissions related to the Initial Public Offering and sale of the Over-Allotment Units. In addition, the underwriters agreed to defer $9.9 million in underwriting discounts and commissions.
Item 3. | Defaults Upon Senior Securities |
None.
Item 4. | Mine Safety Disclosures. |
Not applicable.
Item 5. | Other Information. |
None.
26
Item 6. | Exhibits. |
* | Filed herewith |
+ | These certifications are furnished to the SEC pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing. |
27
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: November 14, 2022 | WARBURG PINCUS CAPITAL CORPORATION I-A | |||||
By: | /s/ Christopher H. Turner | |||||
Name: | Christopher H. Turner | |||||
Title: | Chief Executive Officer and Chairman of the Board of Directors | |||||
(Principal Executive Officer) |
28
1 Year Warburg Pincus Capital C... Chart |
1 Month Warburg Pincus Capital C... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions